Patents by Inventor Aurélien TAP

Aurélien TAP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrocyclic RIP2-kinase inhibitors
    Patent number: 12630563
    Abstract: The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2-kinase, and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent. In particular, the present disclosure relates to a compound according to Formula(I): or a stereoisomer, tautomer, racemate, salt, hydrate, N-oxide form, or solvate thereof.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: May 19, 2026
    Assignee: Oncodesign S.A.
    Inventors: Yann Lamotte, Nérina Dodic, Aurélien Tap, Alexis Denis, Jean-Marie Brusq, Mourad Daoubi Khamlichi, Pascal André René Benderitter
  • MACROCYCLIC RIP2-KINASE INHIBITORS
    Publication number: 20260125396
    Abstract: The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2-kinase, and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
    Type: Application
    Filed: December 29, 2025
    Publication date: May 7, 2026
    Applicant: Oncodesign S.A.
    Inventors: Yann LAMOTTE, Nérina DODIC, Aurélien TAP, Alexis DENIS, Jean-Marie BRUSO, Mourad DAOUBI KHAMLICHI, Pascal André René BENDERITTER
  • MACROCYCLIC RIP2-KINASE INHIBITORS
    Publication number: 20230126352
    Abstract: The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2-kinase, and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
    Type: Application
    Filed: February 1, 2021
    Publication date: April 27, 2023
    Applicant: Oncodesign SA
    Inventors: Yann LAMOTTE, Nérina DODIC, Aurélien TAP, Alexis DENIS, Jean-Marie BRUSO, Mourad DAOUBI KHAMLICHI, Pascal André Rene PENDERITTER